Pronova BioPharma Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Oslo Norway (1917)
Status: Acquired by BASF (2012) → now IG Farben (1925)

Organization Overview

First Clinical Trial
1995
NCT01422317
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pronova BioPharma ASA